Report Detail
Global Angina Pectoris Drugs Market Insights, Forecast to 2025
- RnM2814721 |
- 14 May, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Angina pectoris is a clinical indication characterized by precordial heaviness or discomfort due to transient myocardial ischemia without infarction, elicited by physical exertion or psychological stress. Angina pectoris is categorized as - stable, unstable, microvascular and Prinzmetal / variant. Angina pectoris is an initial presentation of coronary heart disease (CHD) and exerts a major impact on quality of life (QOL), costs to the society and ability to work.
Chronic stable angina pectoris has a prevalence of 2.0 - 4.0% in the seven major markets (U.S., U.K., Germany, France, Italy, Spain, Japan). Heart Disease and Stroke Statistics from American Heart Association estimates indicate that over nine million adults in the U.S. have chronic angina pectoris.
The global Angina Pectoris Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Angina Pectoris Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Angina Pectoris Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Angina Pectoris Drugs in these regions.
This research report categorizes the global Angina Pectoris Drugs market by top players/brands, region, type and end user. This report also studies the global Angina Pectoris Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Bayer
AstraZeneca
Gilead
Novartis
GlaxoSmithKline
Merck
Mylan
Teva Pharmaceutical
Market size by Product
Beta Blockers
Calcium Antagonists
Anticoagulants
Anti-Platelets
Others
Market size by End User
Hospitals
Clinics
ASCs
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Angina Pectoris Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Angina Pectoris Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Angina Pectoris Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Angina Pectoris Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Angina Pectoris Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Angina Pectoris Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Angina Pectoris Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Angina Pectoris Drugs Market Size Growth Rate by Product
- 1.4.2 Beta Blockers
- 1.4.3 Calcium Antagonists
- 1.4.4 Anticoagulants
- 1.4.5 Anti-Platelets
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Angina Pectoris Drugs Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 ASCs
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Angina Pectoris Drugs Market Size
- 2.1.1 Global Angina Pectoris Drugs Revenue 2014-2025
- 2.1.2 Global Angina Pectoris Drugs Sales 2014-2025
- 2.2 Angina Pectoris Drugs Growth Rate by Regions
- 2.2.1 Global Angina Pectoris Drugs Sales by Regions
- 2.2.2 Global Angina Pectoris Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Angina Pectoris Drugs Sales by Manufacturers
- 3.1.1 Angina Pectoris Drugs Sales by Manufacturers
- 3.1.2 Angina Pectoris Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Angina Pectoris Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Angina Pectoris Drugs Revenue by Manufacturers
- 3.2.1 Angina Pectoris Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Angina Pectoris Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Angina Pectoris Drugs Price by Manufacturers
- 3.4 Angina Pectoris Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Angina Pectoris Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Angina Pectoris Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Angina Pectoris Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Angina Pectoris Drugs Sales by Product
- 4.2 Global Angina Pectoris Drugs Revenue by Product
- 4.3 Angina Pectoris Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Angina Pectoris Drugs Breakdown Data by End User
6 North America
- 6.1 North America Angina Pectoris Drugs by Countries
- 6.1.1 North America Angina Pectoris Drugs Sales by Countries
- 6.1.2 North America Angina Pectoris Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Angina Pectoris Drugs by Product
- 6.3 North America Angina Pectoris Drugs by End User
7 Europe
- 7.1 Europe Angina Pectoris Drugs by Countries
- 7.1.1 Europe Angina Pectoris Drugs Sales by Countries
- 7.1.2 Europe Angina Pectoris Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Angina Pectoris Drugs by Product
- 7.3 Europe Angina Pectoris Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Angina Pectoris Drugs by Countries
- 8.1.1 Asia Pacific Angina Pectoris Drugs Sales by Countries
- 8.1.2 Asia Pacific Angina Pectoris Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Angina Pectoris Drugs by Product
- 8.3 Asia Pacific Angina Pectoris Drugs by End User
9 Central & South America
- 9.1 Central & South America Angina Pectoris Drugs by Countries
- 9.1.1 Central & South America Angina Pectoris Drugs Sales by Countries
- 9.1.2 Central & South America Angina Pectoris Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Angina Pectoris Drugs by Product
- 9.3 Central & South America Angina Pectoris Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Angina Pectoris Drugs by Countries
- 10.1.1 Middle East and Africa Angina Pectoris Drugs Sales by Countries
- 10.1.2 Middle East and Africa Angina Pectoris Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Angina Pectoris Drugs by Product
- 10.3 Middle East and Africa Angina Pectoris Drugs by End User
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pfizer Angina Pectoris Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pfizer Angina Pectoris Drugs Products Offered
- 11.1.5 Pfizer Recent Development
- 11.2 Bayer
- 11.2.1 Bayer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bayer Angina Pectoris Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bayer Angina Pectoris Drugs Products Offered
- 11.2.5 Bayer Recent Development
- 11.3 AstraZeneca
- 11.3.1 AstraZeneca Company Details
- 11.3.2 Company Business Overview
- 11.3.3 AstraZeneca Angina Pectoris Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 AstraZeneca Angina Pectoris Drugs Products Offered
- 11.3.5 AstraZeneca Recent Development
- 11.4 Gilead
- 11.4.1 Gilead Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Gilead Angina Pectoris Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Gilead Angina Pectoris Drugs Products Offered
- 11.4.5 Gilead Recent Development
- 11.5 Novartis
- 11.5.1 Novartis Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Novartis Angina Pectoris Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Novartis Angina Pectoris Drugs Products Offered
- 11.5.5 Novartis Recent Development
- 11.6 GlaxoSmithKline
- 11.6.1 GlaxoSmithKline Company Details
- 11.6.2 Company Business Overview
- 11.6.3 GlaxoSmithKline Angina Pectoris Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 GlaxoSmithKline Angina Pectoris Drugs Products Offered
- 11.6.5 GlaxoSmithKline Recent Development
- 11.7 Merck
- 11.7.1 Merck Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Merck Angina Pectoris Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Merck Angina Pectoris Drugs Products Offered
- 11.7.5 Merck Recent Development
- 11.8 Mylan
- 11.8.1 Mylan Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Mylan Angina Pectoris Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Mylan Angina Pectoris Drugs Products Offered
- 11.8.5 Mylan Recent Development
- 11.9 Teva Pharmaceutical
- 11.9.1 Teva Pharmaceutical Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Teva Pharmaceutical Angina Pectoris Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Teva Pharmaceutical Angina Pectoris Drugs Products Offered
- 11.9.5 Teva Pharmaceutical Recent Development
12 Future Forecast
- 12.1 Angina Pectoris Drugs Market Forecast by Regions
- 12.1.1 Global Angina Pectoris Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Angina Pectoris Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Angina Pectoris Drugs Market Forecast by Product
- 12.2.1 Global Angina Pectoris Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Angina Pectoris Drugs Revenue Forecast by Product 2019-2025
- 12.3 Angina Pectoris Drugs Market Forecast by End User
- 12.4 North America Angina Pectoris Drugs Forecast
- 12.5 Europe Angina Pectoris Drugs Forecast
- 12.6 Asia Pacific Angina Pectoris Drugs Forecast
- 12.7 Central & South America Angina Pectoris Drugs Forecast
- 12.8 Middle East and Africa Angina Pectoris Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Angina Pectoris Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Angina Pectoris Drugs . Industry analysis & Market Report on Angina Pectoris Drugs is a syndicated market report, published as Global Angina Pectoris Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Angina Pectoris Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
